Skip to main content
. Author manuscript; available in PMC: 2017 Feb 20.
Published in final edited form as: Transfusion. 2009 Jun 23;49(10):2090–2096. doi: 10.1111/j.1537-2995.2009.02255.x

TABLE 1.

Inhibition of antibodies to high-prevalence Scianna antigens and lack of inhibition of antibodies to various common blood group antigens by soluble recombinant Scianna protein

Reactivity in gel matrix test*
Samples and
antibody specificities
With Scianna
protein
Without Scianna
protein
Anti-Sc1
  Sample 1 0 2+
  Sample 2 0 1.5+
  Sample 3 0 2+
Anti-Sc2
  Sample 1 3.5+ 3.5+
  Sample 2 2+ 2+
  Sample 3 2.5+ 2.5+
Anti-Sc5 0 2+
Anti-D 3+ 3+
Anti-C 3+ 3+
Anti-c 3+ 3+
Anti-E 3+ 3+
Anti-e 3+ 3+
Anti-K 3+ 3+
Anti-k 2+ 2+
Anti-M 3+ 3+
Anti-N 2+ 2+
Anti-S 3+ 3+
Anti-s 2.5+ 2.5+
Anti-Jka 1.5+ 1.5+
Anti-Jkb 1.5+ 1.5+
Anti-Fya 2+ 2+
Anti-Fyb 2+ 2+
Anti-Kna 1.5+ 1.5+
Anti-Lub 2+ 2+
Anti-Vel 2.5+ 2.5+
Anti-Jra 1.5+ 1.5+
Anti-Cha 1+ 1+
Anti-JMH 1.5+ 1.5+
*

Antiglobulin technique.

All samples tested are shown for anti-Scianna specificities. Only representative results are shown for the antibody specificities other than anti-Scianna; for a full list of the antisera tested see Materials and Methods section.